Cuprina Holdings (Cayman) Ltd. has announced progress on several research studies in collaboration with prominent educational institutes focusing on the development of innovative biomedical and cosmeceutical products. The company is exploring the use of collagen peptides derived from American bullfrog skin for diverse applications, including 3D printable wound care dressings and microneedling patches. These studies are conducted in collaboration with the National University of Singapore and the Singapore Institute of Technology. Cuprina is also investigating the production of superior powdered bullfrog collagen peptides for cosmeceuticals. Results from these studies are anticipated to enhance product offerings in wound care and beauty sectors, with ongoing testing to determine their efficacy. Further updates will be provided as research progresses and results become available.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.